Is there a role for surgery for microprolactinomas?

Michael Y. Wang, Martin H. Weiss

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The neurosurgical and endocrinologic treatment of prolactinomas has undergone significant advances in the past three decades. Because of medical progress, we are now confronted with two safe, effective approaches for treating prolactinomas. Transsphenoidal surgery for microprolactinomas carries a 90% cure rate while incurring minimal risks, and offers the only opportunity for endocrinologic and oncologic cure. Alternatively, treatment with bromocriptine and other dopaminergic agents also results in effective chemical control in greater than 90% of cases but requires lifelong treatment. Pharmacologic control of microprolactinomas remains the mainstay of treatment, but surgical indications include patients intolerant of medical treatment, failing medical therapy, and desiring pregnancy. Young patients wishing to avoid lifelong medical treatment may also be operative candidates. In these situations surgery is a vital adjunct in the management of prolactinoma-secreting microadenomas.

Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalSeminars in Neurosurgery
Volume12
Issue number3
StatePublished - Sep 1 2001
Externally publishedYes

Fingerprint

Prolactinoma
Therapeutics
Dopamine Agents
Bromocriptine
Pregnancy

Keywords

  • Bromocriptine
  • Pituitary adenoma
  • Prolactinoma
  • Transsphenoidal surgery

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Wang, M. Y., & Weiss, M. H. (2001). Is there a role for surgery for microprolactinomas? Seminars in Neurosurgery, 12(3), 289-294.

Is there a role for surgery for microprolactinomas? / Wang, Michael Y.; Weiss, Martin H.

In: Seminars in Neurosurgery, Vol. 12, No. 3, 01.09.2001, p. 289-294.

Research output: Contribution to journalArticle

Wang, MY & Weiss, MH 2001, 'Is there a role for surgery for microprolactinomas?', Seminars in Neurosurgery, vol. 12, no. 3, pp. 289-294.
Wang, Michael Y. ; Weiss, Martin H. / Is there a role for surgery for microprolactinomas?. In: Seminars in Neurosurgery. 2001 ; Vol. 12, No. 3. pp. 289-294.
@article{cdcebb48afc54b37bc685dbb7e7976ee,
title = "Is there a role for surgery for microprolactinomas?",
abstract = "The neurosurgical and endocrinologic treatment of prolactinomas has undergone significant advances in the past three decades. Because of medical progress, we are now confronted with two safe, effective approaches for treating prolactinomas. Transsphenoidal surgery for microprolactinomas carries a 90{\%} cure rate while incurring minimal risks, and offers the only opportunity for endocrinologic and oncologic cure. Alternatively, treatment with bromocriptine and other dopaminergic agents also results in effective chemical control in greater than 90{\%} of cases but requires lifelong treatment. Pharmacologic control of microprolactinomas remains the mainstay of treatment, but surgical indications include patients intolerant of medical treatment, failing medical therapy, and desiring pregnancy. Young patients wishing to avoid lifelong medical treatment may also be operative candidates. In these situations surgery is a vital adjunct in the management of prolactinoma-secreting microadenomas.",
keywords = "Bromocriptine, Pituitary adenoma, Prolactinoma, Transsphenoidal surgery",
author = "Wang, {Michael Y.} and Weiss, {Martin H.}",
year = "2001",
month = "9",
day = "1",
language = "English",
volume = "12",
pages = "289--294",
journal = "Seminars in Neurosurgery",
issn = "1526-8012",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Is there a role for surgery for microprolactinomas?

AU - Wang, Michael Y.

AU - Weiss, Martin H.

PY - 2001/9/1

Y1 - 2001/9/1

N2 - The neurosurgical and endocrinologic treatment of prolactinomas has undergone significant advances in the past three decades. Because of medical progress, we are now confronted with two safe, effective approaches for treating prolactinomas. Transsphenoidal surgery for microprolactinomas carries a 90% cure rate while incurring minimal risks, and offers the only opportunity for endocrinologic and oncologic cure. Alternatively, treatment with bromocriptine and other dopaminergic agents also results in effective chemical control in greater than 90% of cases but requires lifelong treatment. Pharmacologic control of microprolactinomas remains the mainstay of treatment, but surgical indications include patients intolerant of medical treatment, failing medical therapy, and desiring pregnancy. Young patients wishing to avoid lifelong medical treatment may also be operative candidates. In these situations surgery is a vital adjunct in the management of prolactinoma-secreting microadenomas.

AB - The neurosurgical and endocrinologic treatment of prolactinomas has undergone significant advances in the past three decades. Because of medical progress, we are now confronted with two safe, effective approaches for treating prolactinomas. Transsphenoidal surgery for microprolactinomas carries a 90% cure rate while incurring minimal risks, and offers the only opportunity for endocrinologic and oncologic cure. Alternatively, treatment with bromocriptine and other dopaminergic agents also results in effective chemical control in greater than 90% of cases but requires lifelong treatment. Pharmacologic control of microprolactinomas remains the mainstay of treatment, but surgical indications include patients intolerant of medical treatment, failing medical therapy, and desiring pregnancy. Young patients wishing to avoid lifelong medical treatment may also be operative candidates. In these situations surgery is a vital adjunct in the management of prolactinoma-secreting microadenomas.

KW - Bromocriptine

KW - Pituitary adenoma

KW - Prolactinoma

KW - Transsphenoidal surgery

UR - http://www.scopus.com/inward/record.url?scp=0035468325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035468325&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035468325

VL - 12

SP - 289

EP - 294

JO - Seminars in Neurosurgery

JF - Seminars in Neurosurgery

SN - 1526-8012

IS - 3

ER -